A detailed history of Trexquant Investment LP transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Trexquant Investment LP holds 440,418 shares of EBS stock, worth $4.76 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
440,418
Holding current value
$4.76 Million
% of portfolio
0.05%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.72 - $14.77 $2.52 Million - $6.5 Million
440,418 New
440,418 $3.68 Million
Q1 2023

May 15, 2023

BUY
$7.79 - $16.29 $488,417 - $1.02 Million
62,698 New
62,698 $649,000
Q3 2022

Nov 14, 2022

BUY
$20.09 - $35.8 $289,537 - $515,949
14,412 Added 91.93%
30,089 $632,000
Q2 2022

Aug 11, 2022

SELL
$27.42 - $43.63 $881,799 - $1.4 Million
-32,159 Reduced 67.23%
15,677 $487,000
Q1 2022

May 13, 2022

BUY
$36.48 - $52.22 $1.75 Million - $2.5 Million
47,836 New
47,836 $1.96 Million
Q4 2021

Feb 14, 2022

SELL
$33.11 - $55.01 $463,540 - $770,140
-14,000 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$50.07 - $66.05 $700,980 - $924,700
14,000 New
14,000 $701,000
Q2 2021

Aug 12, 2021

SELL
$56.61 - $80.46 $223,156 - $317,173
-3,942 Closed
0 $0
Q1 2021

May 13, 2021

BUY
$86.23 - $125.19 $339,918 - $493,498
3,942 New
3,942 $366,000
Q4 2020

Feb 11, 2021

SELL
$79.17 - $111.47 $1.36 Million - $1.92 Million
-17,221 Closed
0 $0
Q3 2020

Nov 06, 2020

BUY
$81.91 - $134.94 $1.41 Million - $2.32 Million
17,221 New
17,221 $1.78 Million
Q2 2020

Aug 07, 2020

SELL
$54.33 - $89.52 $481,418 - $793,236
-8,861 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$49.34 - $68.76 $437,201 - $609,282
8,861 New
8,861 $513,000
Q1 2018

May 03, 2018

SELL
$44.44 - $54.39 $472,619 - $578,437
-10,635 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$37.77 - $47.75 $401,683 - $507,821
10,635
10,635 $494,000

Others Institutions Holding EBS

About Emergent BioSolutions Inc.


  • Ticker EBS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,861,500
  • Market Cap $539M
  • Description
  • Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...
More about EBS
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.